FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783187430> ?p ?o ?g. }

• W2783187430 endingPage "736" @default.
• W2783187430 startingPage "729" @default.
• W2783187430 abstract "Background A major component of sputum in cystic fibrosis (CF) patients is polymerized DNA, a byproduct of degraded neutrophils. Dornase alfa (dornase) selectively cleaves extracellular DNA and reduces the viscosity of sputum. It improves mucociliary clearance and pulmonary function. The benefit of dornase on CF‐associated sinusitis is less clear. Therefore, the objective of this study was to systematically review the use of dornase on chronic rhinosinusitis (CRS) in CF patients. Methods The Preferred Reporting Items for Systematic Reviews and Meta‐Analyses statement was followed for this systematic review. Ovid Medline, EMBASE, PubMed, and the Cochrane Library were searched. The search terms “dornase alfa,” “deoxyribonucleases,” “rhinosinusitis,” and “cystic fibrosis” were used to find articles published between 1990 and 2016. The articles were reviewed for study design, level of evidence, and clinical outcomes. Results Sixty‐two articles were identified; 6 met the inclusion criteria (104 patients). Improvement measured by sinonasal symptoms, endoscopic and radiographic findings, and pulmonary function was variably reported between the studies. Sinonasal symptoms were shown to improve in all studies with use of intranasal topical dornase. Three placebo‐controlled studies showed that topical dornase significantly improved sinonasal symptoms more than saline alone. The impact on pulmonary function and radiographic and endoscopy findings was variable. Conclusion Topical intranasal dornase appears to improve sinonasal symptoms in CF patients to a greater degree than saline alone. The impact on other outcomes is less clear. Larger studies are needed to fully elucidate the true efficacy of dornase alfa in the treatment of CRS in CF patients." @default.
• W2783187430 created "2018-01-26" @default.
• W2783187430 creator A5000453500 @default.
• W2783187430 creator A5006742437 @default.
• W2783187430 creator A5011624902 @default.
• W2783187430 creator A5015390498 @default.
• W2783187430 date "2018-01-11" @default.
• W2783187430 modified "2023-09-27" @default.
• W2783187430 title "Treatment of chronic rhinosinusitis with dornase alfa in patients with cystic fibrosis: a systematic review" @default.
• W2783187430 cites W1483191100 @default.
• W2783187430 cites W175998601 @default.
• W2783187430 cites W1965385540 @default.
• W2783187430 cites W1998624561 @default.
• W2783187430 cites W2015409571 @default.
• W2783187430 cites W2018397412 @default.
• W2783187430 cites W2030810985 @default.
• W2783187430 cites W2040283107 @default.
• W2783187430 cites W2041903392 @default.
• W2783187430 cites W2058432179 @default.
• W2783187430 cites W2070408984 @default.
• W2783187430 cites W2072540983 @default.
• W2783187430 cites W2076340280 @default.
• W2783187430 cites W2081548537 @default.
• W2783187430 cites W2086180508 @default.
• W2783187430 cites W2112485011 @default.
• W2783187430 cites W2114074118 @default.
• W2783187430 cites W2116475791 @default.
• W2783187430 cites W2163036087 @default.
• W2783187430 cites W2317193579 @default.
• W2783187430 cites W2321221473 @default.
• W2783187430 cites W2417886070 @default.
• W2783187430 cites W2576440140 @default.
• W2783187430 cites W4210449212 @default.
• W2783187430 cites W4240221768 @default.
• W2783187430 doi "https://doi.org/10.1002/alr.22082" @default.
• W2783187430 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29323796" @default.
• W2783187430 hasPublicationYear "2018" @default.
• W2783187430 type Work @default.
• W2783187430 sameAs 2783187430 @default.
• W2783187430 citedByCount "16" @default.
• W2783187430 countsByYear W27831874302018 @default.
• W2783187430 countsByYear W27831874302019 @default.
• W2783187430 countsByYear W27831874302020 @default.
• W2783187430 countsByYear W27831874302021 @default.
• W2783187430 countsByYear W27831874302022 @default.
• W2783187430 countsByYear W27831874302023 @default.
• W2783187430 crossrefType "journal-article" @default.
• W2783187430 hasAuthorship W2783187430A5000453500 @default.
• W2783187430 hasAuthorship W2783187430A5006742437 @default.
• W2783187430 hasAuthorship W2783187430A5011624902 @default.
• W2783187430 hasAuthorship W2783187430A5015390498 @default.
• W2783187430 hasConcept C108516343 @default.
• W2783187430 hasConcept C114682108 @default.
• W2783187430 hasConcept C126322002 @default.
• W2783187430 hasConcept C141071460 @default.
• W2783187430 hasConcept C142724271 @default.
• W2783187430 hasConcept C17744445 @default.
• W2783187430 hasConcept C189708586 @default.
• W2783187430 hasConcept C199539241 @default.
• W2783187430 hasConcept C204787440 @default.
• W2783187430 hasConcept C27081682 @default.
• W2783187430 hasConcept C2776301714 @default.
• W2783187430 hasConcept C2776938444 @default.
• W2783187430 hasConcept C2777714996 @default.
• W2783187430 hasConcept C2777768476 @default.
• W2783187430 hasConcept C2779473830 @default.
• W2783187430 hasConcept C2781069245 @default.
• W2783187430 hasConcept C3019717275 @default.
• W2783187430 hasConcept C501107679 @default.
• W2783187430 hasConcept C71924100 @default.
• W2783187430 hasConceptScore W2783187430C108516343 @default.
• W2783187430 hasConceptScore W2783187430C114682108 @default.
• W2783187430 hasConceptScore W2783187430C126322002 @default.
• W2783187430 hasConceptScore W2783187430C141071460 @default.
• W2783187430 hasConceptScore W2783187430C142724271 @default.
• W2783187430 hasConceptScore W2783187430C17744445 @default.
• W2783187430 hasConceptScore W2783187430C189708586 @default.
• W2783187430 hasConceptScore W2783187430C199539241 @default.
• W2783187430 hasConceptScore W2783187430C204787440 @default.
• W2783187430 hasConceptScore W2783187430C27081682 @default.
• W2783187430 hasConceptScore W2783187430C2776301714 @default.
• W2783187430 hasConceptScore W2783187430C2776938444 @default.
• W2783187430 hasConceptScore W2783187430C2777714996 @default.
• W2783187430 hasConceptScore W2783187430C2777768476 @default.
• W2783187430 hasConceptScore W2783187430C2779473830 @default.
• W2783187430 hasConceptScore W2783187430C2781069245 @default.
• W2783187430 hasConceptScore W2783187430C3019717275 @default.
• W2783187430 hasConceptScore W2783187430C501107679 @default.
• W2783187430 hasConceptScore W2783187430C71924100 @default.
• W2783187430 hasIssue "6" @default.
• W2783187430 hasLocation W27831874301 @default.
• W2783187430 hasLocation W27831874302 @default.
• W2783187430 hasOpenAccess W2783187430 @default.
• W2783187430 hasPrimaryLocation W27831874301 @default.
• W2783187430 hasRelatedWork W1923725448 @default.
• W2783187430 hasRelatedWork W1975576049 @default.
• W2783187430 hasRelatedWork W198533119 @default.
• W2783187430 hasRelatedWork W1988200986 @default.

• next